World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4422)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

216

WORD

HTML

2200

Figures (1-5)

396

Tables (1-1)

439

Sum=3251

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

250

Download

720

Sum=970

Mar 15, 2024 (publication date) through Nov 14, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Wu QS, Zheng DN, Ji C, Qian H, Jin J, He Q. MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4. World J Diabetes 2024; 15(3): 488-501 [PMID: 38591087 DOI: 10.4239/wjd.v15.i3.488]
URL:	https://www.wjgnet.com/1948-9358/full/v15/i3/488.htm

Number	Citing Articles
1	Shan Gao. Crosstalk between microRNAs and autophagy in adipocyte differentiation: emerging therapeutic targets for obesity. Adipocyte 2025; 14(1) doi: 10.1080/21623945.2025.2580741
2	You Wang, Yuan Wang, Pei Pi, Dan Luo, Min Ning, Gang Ye. MiR-203 improved renal cell injury in diabetic nephropathy by targeting SOCS6/SOCS7 and inhibiting JAK/STAT pathway activation. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-95952-5
3	Javier Donate-Correa, Ainhoa González-Luis, Jésica Díaz-Vera, Juan Ramón Hernandez-Fernaud. MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease. World Journal of Diabetes 2024; 15(7): 1398-1403 doi: 10.4239/wjd.v15.i7.1398 Abstract(589) \| Core Tip(592) \| Full Article(HTML)(1441) \| Full Article with Cover (PDF)-789K(203) \| Audio-207K(58) \| Peer-Review Report-221K(93) \| Answering Reviewers-61K(81) \| Full Article (PDF)-558K(146) \| Full Article (XML)-82K(74) \| Times Cited (1) \| Total Visits (4793) \| Open
4	Jiamian Geng, Sijia Ma, Hui Tang, Chun Zhang. Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update. Biomedicines 2025; 13(6): 1424 doi: 10.3390/biomedicines13061424
5	Ashraf Al Madhoun. MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease. World Journal of Diabetes 2024; 15(9): 1837-1841 doi: 10.4239/wjd.v15.i9.1837 Abstract(543) \| Core Tip(526) \| Full Article(HTML)(1467) \| Full Article with Cover (PDF)-739K(123) \| Full Article (Word)-27K(2) \| Audio-1352K(5) \| Peer-Review Report-194K(74) \| Answering Reviewers-54K(90) \| Full Article (PDF)-371K(119) \| Full Article (XML)-74K(77) \| Times Cited (0) \| Total Visits (4741) \| Open